1. Home
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Poc Hba1C Testing Global Market Report 2022

Poc Hba1C Testing Global Market Report 2022

  • September 2022
  • 175 pages
  • ID: 6320345
  • Format: PDF
  • The Business Research Company


Table of Contents

Major Players in the POC HbA1C testing market include Bio-Rad Laboratories, Inc, Siemens Healthineers AG, Menarini Group, F. Hoffmann-La Roche Ltd., and ARKRAY Inc.

The global POC HbA1C testing market is expected to grow from $1.53 billion in 2021 to $1.73 billion in 2022 at a compound annual growth rate (CAGR) of 13.2%. The POC HbA1C market is expected to grow to $2.43 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%.

The point of care (POC) hemoglobin (Hb) A1C testing market consists of sales of POC HbA1C testing devices and related services by entities (organizations, sole traders, partnership) that assess the average level of blood sugar over 2 to 3 months in an individual.POC HbA1C testing devices are designed to diagnose average levels of glucose in patients’ blood and to control type I and type II diabetes mellitus.

Diabetes is a chronic disease that occurs either when an inadequate amount of insulin is produced by the pancreas or when the body cannot use the insulin it produces effectively. Insulin is a hormone that regulates blood sugar.

The main products of Poc Hba1C testing are instruments and consumables.Instruments refer to a measuring device for determining the present value of a quantity under observation.

The technologies include ion-exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay, and other technologies. The various end-users involved are hospitals, physician offices/outpatient centers, home care, and other end-users.

North America was the largest region in the POC HbA1C testing market in 2021.Africa is expected to be the fastest-growing region in the forecast- period.

The regions covered in POC HbA1C testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The increasing prevalence of diabetes is expected to propel the growth of the POC HbA1C testing market.Long working hours, less physical activity, and unhealthy eating and drinking habits are increasing the prevalence of diabetes.

Diabetes can be diagnosed and monitored with point-of-care (POC) HbA1c assays, which can be utilized in community settings and healthcare facilities without laboratories.According to the report published by the International Diabetes Federation, a Belgium-based umbrella organization of over 230 national diabetes associations, in 2021, there are 463 million individuals living with diabetes around the world 2019 an increase to 537 million in 2021.

Also, by the year 2030, the overall number of diabetics is expected to reach 643 million, and by 2045, it will reach 783 million. Therefore, the increasing prevalence of diabetes is driving the growth of the POC HbA1C testing market.

Technological advances are a key trend gaining popularity in the POC HbA1C testing market.Major players in the market are investing in developing advanced technologies to provide fast, accurate results in a short period thereby helping laboratories to manage the increase in demand for testing.

For instance, in June 2019, Abbott, a US-based medical devices and health care company, introduced Afinion™ HbA1c Dx assay, an in vitro diagnostic test for the quantitative determination of HbA1c in human venous and capillary whole blood for use on the Afinion 2 Analyzer, and also Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the only rapid POC test cleared by the U.S. Food and Drug Administration (FDA) to assist healthcare professionals in diagnosing diabetes and also determining the patient’s risk of developing the disorder. The test provides reliable and accurate results of 1,2 glycated hemoglobin in just three minutes, helping physicians to evaluate patients and enabling them to formulate individualized care plans during a single visit to the doctor`s office.

In May 2020, EKF Diagnostics, a Germany-based in vitro diagnostics company has partnered with Tosoh Europe N.V. for an undisclosed amount. The three-year distribution agreement with Tosoh Europe N.V. is for the distribution of its Quo-Test HbA1c point-of-care (POC) analyzer in the Middle East and Africa. Tosoh Bioscience is a Japan-based chemical and specialty materials company.

The countries covered in the POC Hba1C testing market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

United States Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

  • $ 2490
  • January 2023
  • 125 pages

United States Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis United States Diabetes Market is expected to reach US$ 28.27 Billion ...

  • United States
  • Diabetes
  • Insulin Delivery
  • Industry analysis
  • Overweight Prevalence
  • Diabetes Prevalence

Global Diabetes Drugs Industry $ 4950 October 2022


Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on